NHS Shropshire CCG effective shared care agreements

The following documents are available to download:

• Apomorphine SCA
• Azathioprine Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)
• Ciclosporin Oral Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)
• Denosumab SCA
• D-Penicillamine Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)
• Disease-modifying antirheumatic drugs (DMARDs) shared care agreement (May 2018)
• Hydroxychloroquine Rheumatology Local Safety Monitoring Schedule (Oct 2020)
• Leflunomide Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)
• Methotrexate Oral and Parenteral Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)
• Mycophenolate Mofetil Rheumatology Local Safety Monitoring Schedule (March 2018)
• Sodium aurothiomalate (Gold therapy) Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)
• Somatropin (recombinant Human Growth Hormone) treatment in adults
• Sulfasalazine Rheumatology Local Safety Monitoring Schedule for Shared Care (co-developed with RJAH) (March 2018)

Disease-modifying antirheumatic drugs (DMARDs) pathway
Patient Pathway for Initiating and Monitoring DMARDs in Rheumatology Service (June 2018)
Shared Care Agreement – DMARDs
Please see the Shared Care Agreements page for drug-specific shared care agreement documents

Mental Health Effective Shared Care Agreements

• Access Effective shared care agreements on Midlands Partnership NHS Foundation Trust (MPFT) website - please note as from Friday, 1 June, 2018, South Staffordshire and Shropshire Healthcare NHS Foundation Trust ceases to exist having merged with Staffordshire and Stoke on Trent Partnership NHS Trust to from Midlands Partnership NHS Foundation Trust (MPFT).